HRL Form 4/A: Ettinger's Option Award Corrected to 750,000 at $28.30
Rhea-AI Filing Summary
Hormel Foods director and interim CEO Jeffrey M. Ettinger amended a previously reported stock option grant. The correction states the August 5, 2025 option award is for 750,000 common shares with an exercise price of $28.30 and no cash option price paid. The options vest in two equal installments on October 25, 2026 and April 25, 2027 and expire on August 5, 2035. The amendment explains an annual plan limit automatically capped the award at 750,000 shares; the excess previously reported (1,058,800 shares) will instead be expected as a separate option grant in early 2026.
Positive
- Correction provides clarity on the actual number of options awarded (750,000), improving transparency of insider reporting
- Vesting schedule and expiration dates disclosed, allowing investors to see timing of potential insider share realizations
- Plan limit enforcement disclosed, indicating internal governance controls limited the award size
Negative
- None.
Insights
TL;DR: Amendment clarifies award size and timing; cap due to plan limits, with remaining value expected as a later grant.
The Form 4/A corrects the August 5, 2025 disclosure for Jeffrey Ettinger, specifying a capped award of 750,000 stock options at a $28.30 exercise price. The filing is administrative and clarifies that the originally reported larger share count was reduced by an annual participation limit under the 2018 Incentive Compensation Plan. Vesting schedule and expiration are restated, and the filer notes the difference will be delivered as a separate grant in early 2026. For reviewers, this is a corrective disclosure rather than a change in compensation policy.
TL;DR: Governance impact is limited—document corrects award sizing due to plan limits and preserves intended compensation value via a future grant.
The amendment documents that the grant was capped by an annual individual participation limit, a plan-level governance control. The filing preserves transparency by disclosing vesting dates, expiration, and that the shortfall will be granted later. This maintains compliance with Section 16 reporting requirements and clarifies potential dilution timelines without introducing new governance concerns in the document itself.
FAQ
What did Jeffrey M. Ettinger amend on the Form 4/A for HRL?
Why was the number of options reduced to 750,000 in the Form 4/A?
What are the vesting and expiration terms of the corrected option grant?
Will the value not included in the capped award be delivered to Ettinger?
What was the originally reported number of shares on the Original Form 4?